Burns Matteson Capital Management, LLC Pfizer Inc Transaction History

Burns Matteson Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$26.13 - $33.94 $423,070 - $549,522	-16,191 Closed	0 $0
Q3 2023 Jan 12, 2024	BUY	$32.09 - $37.51 $519,569 - $607,324	16,191 New	16,191 $537 Million
Q2 2023 Dec 11, 2023	SELL	$36.12 - $41.79 $457,315 - $529,103	-12,661 Closed	0 $0
Q1 2023 Dec 11, 2023	SELL	$39.39 - $51.28 $13,353 - $17,383	-339 Reduced 2.61%	12,661 $517 Million
Q4 2022 Dec 11, 2023	BUY	$41.75 - $54.5 $542,750 - $708,500	13,000 New	13,000 $666 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Burns Matteson Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Burns Matteson Capital Management, LLC with notifications on news.